747 related articles for article (PubMed ID: 26678891)
41. Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.
Yang L; Song X; Zhu J; Li M; Ji Y; Wu F; Chen Y; Cui X; Hu J; Wang L; Cao Y; Wei Y; Zhang W; Li F
Int J Oncol; 2017 Jul; 51(1):378-388. PubMed ID: 28534990
[TBL] [Abstract][Full Text] [Related]
42. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
43. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
44. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B
PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872
[TBL] [Abstract][Full Text] [Related]
45. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
[TBL] [Abstract][Full Text] [Related]
46. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
Yang Q; Ji G; Li J
Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
48. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
[TBL] [Abstract][Full Text] [Related]
49.
Pan H; Hong Y; Yu B; Li L; Zhang X
Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
[No Abstract] [Full Text] [Related]
50. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
51. MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration.
Li P; Sheng C; Huang L; Zhang H; Huang L; Cheng Z; Zhu Q
Breast Cancer Res; 2014 Nov; 16(6):473. PubMed ID: 25394902
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
Yin W; Shi L; Mao Y
J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
54. MiR-4728-3p could act as a marker of HER2 status.
Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.
Li J; Feng Q; Wei X; Yu Y
Tumour Biol; 2016 Nov; 37(11):15221-15228. PubMed ID: 27683057
[TBL] [Abstract][Full Text] [Related]
56. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
[TBL] [Abstract][Full Text] [Related]
57. Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis.
Zheng SR; Guo GL; Zhang W; Huang GL; Hu XQ; Zhu J; Huang QD; You J; Zhang XH
Oncol Rep; 2012 Apr; 27(4):1149-55. PubMed ID: 22245916
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
59. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
60. Role of miR-647 in human gastric cancer suppression.
Cao W; Wei W; Zhan Z; Xie D; Xie Y; Xiao Q
Oncol Rep; 2017 Mar; 37(3):1401-1411. PubMed ID: 28098914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]